Meiji to acquire Indian contract manufacturing and generic drugs firm Medreich for $290 million
13:15 PM | June 12, 2014 | Natasha Alperowicz
Meiji Holdings (Tokyo), through its Meiji Seika Pharma subsidiary, has agreed to acquire Bangalore, India based Medreich Ltd. Meiji agreed to pay $290 million for Medreich, which in 2013 reported...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.